Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

Published:2019-08 Issue:8 Volume:21 Page:2012-2016
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Anholm Christian¹²^ORCID,Kumarathurai Preman³,Samkani Amirsalar⁴,Pedersen Lene R.³,Boston Raymond C.⁵,Nielsen Olav W.³,Kristiansen Ole P.³,Fenger Mogens⁶,Madsbad Sten⁷,Sajadieh Ahmad³,Haugaard Steen B.²⁴⁸

Affiliation:

1. Department of Internal MedicineCopenhagen University Hospital Glostrup Denmark

2. Department of Internal MedicineCopenhagen University Hospital Amager Denmark

3. Department of CardiologyCopenhagen University Hospital Bispebjerg Denmark

4. Department of EndocrinologyCopenhagen University Hospital Bispebjerg Denmark

5. Departments of Medicine, St. Vincent's HospitalUniversity of Melbourne Fitzroy Victoria Australia

6. Department of Clinical BiochemistryCopenhagen University Hospital Hvidovre Denmark

7. Department of EndocrinologyCopenhagen University Hospital Hvidovre Denmark

8. Clinical Research CentreCopenhagen University Hospital Hvidovre Denmark

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13761

Reference15 articles.

1. Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation

2. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009

3. Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes

4. SERUM-FREE-FATTY-ACIDS AND THEIR RELATION TO COMPLICATIONS AFTER ACUTE MYOCARDIAL INFARCTION

5. Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials;Journal of Diabetes and its Complications;2024-10

2. Liraglutide reduces bone marrow adipogenesis by miR-150-5p/ GDF11 axis in diabetic rats;European Journal of Pharmacology;2024-09

3. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications;Therapeutic Advances in Endocrinology and Metabolism;2024-01

4. Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs;Biomedicine & Pharmacotherapy;2023-12

5. Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetes;BMC Cardiovascular Disorders;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3